Can you help review my U.S. label copy before printing to avoid misbranding risk?

Yes. Share your current label copy + product claims and we will red-flag common U.S. cosmetic misbranding risks and suggest safer wording. Final compliance sign-off should still be done by your U.S. regulatory consultant or counsel.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For U.S. lip care (non-SPF), the biggest label risks we see are drug-like claims (“treats”/”heals”/”repairs eczema”), missing net contents, and incomplete ingredient declaration.
  • Send us your full label text, PDP/back panel layout, and your Amazon bullets; we will review for: product identity (e.g., Lip Balm), net wt in oz + g, INCI ingredient list in descending order, responsible party/distributor name + U.S. address, batch/lot coding, and clear cautions (e.g., external use only where appropriate).
  • If you plan SPF, that typically shifts into OTC requirements (Drug Facts); we can help you choose a safer cosmetic positioning if you want to avoid that path.
  • On OEM/ODM execution: we can do custom formula and lab sampling; typical first samples are 7-14 business days after brief confirmation, with 1-3 revision rounds.
  • MOQ is often 3,000-5,000 pcs per SKU depending on tube/jar and decoration.
  • We can support documentation and testing (COA, SDS, micro/stability/heavy metals) and can arrange third-party testing and track reports.
  • Packaging: we provide full VI and packaging matching (tube, shrink, carton), barcode support, and practical lead time guidance; mass production is commonly 25-35 days after formula/pack approval and deposit, subject to component readiness.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).